BTIG Research Issues Positive Forecast for LifeStance Health Group (NASDAQ:LFST) Stock Price

LifeStance Health Group (NASDAQ:LFST) had its target price hoisted by BTIG Research from $10.00 to $11.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other analysts have also recently commented on LFST. Wall Street Zen cut LifeStance Health Group from a “buy” rating to a “hold” rating in a research report on Saturday. Barclays assumed coverage on shares of LifeStance Health Group in a research note on Tuesday, December 9th. They issued an “overweight” rating and a $8.00 price target on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of LifeStance Health Group in a research report on Monday, December 29th. BMO Capital Markets assumed coverage on shares of LifeStance Health Group in a research report on Thursday, November 13th. They issued an “outperform” rating and a $8.00 target price on the stock. Finally, UBS Group boosted their target price on shares of LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research note on Friday, November 7th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $9.00.

LifeStance Health Group Stock Up 1.6%

LFST stock opened at $7.18 on Monday. The firm has a market cap of $2.79 billion, a PE ratio of -239.33 and a beta of 1.12. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.58 and a current ratio of 1.58. The firm’s fifty day moving average is $6.99 and its 200 day moving average is $5.84. LifeStance Health Group has a one year low of $3.74 and a one year high of $8.30.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The business had revenue of $363.81 million during the quarter, compared to the consensus estimate of $355.06 million. During the same quarter in the prior year, the firm posted ($0.02) earnings per share. The company’s revenue was up 16.3% compared to the same quarter last year. On average, research analysts forecast that LifeStance Health Group will post -0.18 EPS for the current year.

Insider Activity

In other LifeStance Health Group news, insider Lisa K. Miller sold 57,240 shares of the company’s stock in a transaction on Friday, November 21st. The stock was sold at an average price of $6.43, for a total value of $368,053.20. Following the completion of the sale, the insider directly owned 261,292 shares in the company, valued at $1,680,107.56. This represents a 17.97% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Ann Varanakis sold 50,000 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $6.90, for a total value of $345,000.00. Following the completion of the sale, the insider directly owned 315,610 shares of the company’s stock, valued at $2,177,709. This trade represents a 13.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 327,326 shares of company stock worth $2,259,317 over the last ninety days. Corporate insiders own 6.60% of the company’s stock.

Hedge Funds Weigh In On LifeStance Health Group

Several institutional investors and hedge funds have recently bought and sold shares of LFST. Bayesian Capital Management LP acquired a new stake in LifeStance Health Group during the second quarter worth $52,000. Park Edge Advisors LLC grew its holdings in shares of LifeStance Health Group by 14.4% during the 4th quarter. Park Edge Advisors LLC now owns 11,863 shares of the company’s stock worth $84,000 after purchasing an additional 1,495 shares during the period. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of LifeStance Health Group during the 3rd quarter worth about $72,000. Blair William & Co. IL acquired a new stake in shares of LifeStance Health Group during the 2nd quarter worth about $70,000. Finally, Public Employees Retirement System of Ohio purchased a new stake in LifeStance Health Group in the 2nd quarter valued at about $70,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.